The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*Yan Zhao, J Zhang, Liming Wu et al.|British Journal of Dermatology|2021Cited by 73
Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trialsLisa A. Beck, A. Gadkari, Laurent Eckert et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 13